Section Arrow
Quote
PRCT.NASDAQ
- PROCEPT BioRobotics Corp
Quotes are at least 15-min delayed:2025/01/21 05:39 EST
Last
 76.02
-2.82 (-3.58%)
Day High 
79.26 
Prev. Close
78.84 
1-M High
90.47 
Volume 
984.06K 
Bid
72
Ask
83
Day Low
75.75 
Open
79.26 
1-M Low
76 
Market Cap 
4.27B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 83.89 
20-SMA 83.17 
50-SMA 89.76 
52-W High 103.8099 
52-W Low 44.515 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.95/-1.27
Enterprise Value
4.34B
Balance Sheet
Book Value Per Share
4.46
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
6.17M
Operating Revenue Per Share
2.15
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
QSIQuantum-Si2.24-0.3-11.81%-- 
SENSSenseonics Holdings0.8479-0.0271-3.10%-- 
BDMDBaird Medical Investment Holdings Ltd8.85+3.43+63.28%15.32PE
BMRABiomerica0.64-0.066-9.35%-- 
MDTMedtronic plc88.08+0.92+1.06%26.61PE
Quotes are at least 15-min delayed：2025/01/21 05:39 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.